U.S. Markets open in 1 hr 46 mins

Can ZELTIQ Aesthetics (ZLTQ) Run Higher on Strong Earnings Estimate Revisions?

Zacks Equity Research

Medical Products manufacturer ZELTIQ Aesthetics, Inc. (ZLTQ) could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on ZLTQ’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that ZELTIQ Aesthetics could be a solid choice for investors.

Current Quarter Estimates for ZLTQ

In the past 30 days, two estimates have gone higher for ZELTIQ Aesthetics while no downward movement of estimates was observed during the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 19 cents a share 30 days ago, to the loss of 15 cents per share today, an improvement of 21%.

Current Year Estimates for ZLTQ

Meanwhile, ZELTIQ Aesthetics’ current year figures are also looking quite promising, with 3 estimates moving higher in the past month, while none moved lower. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of 58 cents per share 30 days ago to a loss of 54 cents per share today, an improvement of 6.9%.

Bottom Line

The stock has also started to move higher lately, adding 28.9% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #3 (Hold) stock to profit in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




ZELTIQ AESTHETICS INC (ZLTQ): Free Stock Analysis Report


Zacks Investment Research